Rovelizumab

Modify Date: 2024-04-06 09:20:00

Rovelizumab structure	Common Name	Rovelizumab
	CAS Number	339086-79-2	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Rovelizumab

Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke[1].

Name	Rovelizumab

Description	Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke[1].
Related Catalog	Research Areas >> Cardiovascular Disease Signaling Pathways >> Cytoskeleton >> Integrin
In Vitro	Rovelizumab 结合 CD18 并对 CD18 整合素复合物具有活性，包括 CD11b-CD18 异源二聚体[2]。
References	[1]. Jones R. Rovelizumab (ICOS Corp). IDrugs. 2000 Apr;3(4):442-6. [2]. Qualls JE, et al. A double agent in cancer: stopping macrophages wounds tumors. Nat Med. 2010 Aug;16(8):863-4.

No Any Chemical & Physical Properties

Rovelizumab

Use of Rovelizumab

Names

Rovelizumab Biological Activity

Chemical & Physical Properties